Associates L P Venrock Iv Net Worth - Insider Trades and Bio as of May 10, 2026

Associates L P Venrock IV's Net Worth

Estimate Recalculated Sep 19, 2024 01:58AM EST

Who is Associates L P Venrock IV

Associates L P Venrock IV does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include QUANTENNA COMMUNICATIONS INC, Anacor Pharmaceuticals Inc, Bellerophon Therapeutics, Inc., ALIMERA SCIENCES INC, ACCELERON PHARMA INC, and Achaogen Inc.

SEC CIK

Associates L P Venrock IV's CIK is 0001277997

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

QUANTENNA COMMUNICATIONS INC

Investor

Updated Nov 04, 2016


Form 4	20.16%	445.20K	—	—	Nov 04, 2016	2.65M	Options	—	Nov 02
Form 3	—	—	—	—	Oct 27, 2016	—	—	—	—

Showing 2 results

Anacor Pharmaceuticals, Inc.

Investor

Updated Nov 19, 2013


Form 4	-4.03%	-150.00K	$14.06	-$2.11M	Nov 19, 2013	3.58M	Sale	—	Nov 15
Form 4	-0.51%	-19.27K	$6.30	-$121.46K	Sep 24, 2012	3.73M	Sale	—	Sep 20
Form 4	-0.93%	-35.00K	$6.51	-$227.80K	Sep 18, 2012	3.74M	Sale	—	Sep 14
Form 4	-0.66%	-25.18K	$6.59	-$165.93K	Sep 13, 2012	3.78M	Sale	—	Sep 11 - Sep 13
Form 4	-17.74%	-820.55K	—	—	Jul 05, 2012	3.80M	Disposition	—	Jul 02
Form 4	29.62%	600.00K	$5.00	—	Dec 02, 2010	2.63M	Purchase	—	Nov 30
Form 3	—	—	—	—	Nov 23, 2010	—	—	—	—

Showing 7 results

Bellerophon Therapeutics, Inc.

Investor

Updated Oct 28, 2019

View Quote Details


Form 4	-14.53%	-1.09M	$0.48	-$524.96K	Oct 28, 2019	6.44M	Sale	—	Oct 24 - Oct 28
Form 4	-14.53%	-1.09M	$0.48	-$524.96K	Oct 28, 2019	6.44M	Sale	—	Oct 24 - Oct 28
Form 4	1.93%	142.86K	$0.70	$100.00K	Mar 14, 2019	7.53M	Purchase	—	Jan 23
Form 4	1.93%	142.86K	$0.70	$100.00K	Mar 14, 2019	7.53M	Purchase	—	Jan 23
Form 4	2.93%	210.00K	$1.20	$252.35K	Sep 17, 2018	7.39M	Purchase	—	Sep 13 - Sep 17
Form 4	2.93%	210.00K	$1.20	$252.35K	Sep 17, 2018	7.39M	Purchase	—	Sep 13 - Sep 17
Form 4	7.09%	475.00K	$1.18	$558.39K	Sep 12, 2018	7.18M	Purchase	—	Sep 10 - Sep 12
Form 4	7.09%	475.00K	$1.18	$558.39K	Sep 12, 2018	7.18M	Purchase	—	Sep 10 - Sep 12
Form 4	2.45%	160.00K	$0.86	$138.16K	Sep 07, 2018	6.70M	Purchase	—	Sep 05 - Sep 07
Form 4	2.45%	160.00K	$0.86	$138.16K	Sep 07, 2018	6.70M	Purchase	—	Sep 05 - Sep 07
Form 4	8.81%	529.37K	$0.65	$342.88K	Aug 16, 2018	6.54M	Purchase	—	Aug 14 - Aug 16
Form 4	8.81%	529.37K	$0.65	$342.88K	Aug 16, 2018	6.54M	Purchase	—	Aug 14 - Aug 16
Form 3	—	—	—	—	Aug 16, 2018	6.01M	—	—	—
Form 3	—	—	—	—	Aug 16, 2018	6.01M	—	—	—

Showing 14 results

ALIMERA SCIENCES INC

Investor

Updated May 10, 2011

View Quote Details


Form 4	-11.90%	-838.71K	—	—	May 10, 2011	6.21M	Disposition	—	May 06
Form 4	8.40%	306.07K	$11.00	—	Apr 28, 2010	3.95M	Purchase	—	Apr 27
Form 3	—	—	—	—	Apr 21, 2010	—	—	—	—

Showing 3 results

ACCELERON PHARMA INC

Investor

Updated Sep 25, 2013


Form 3/A	—	—	—	—	Sep 25, 2013	—	—	—	—
Form 3	—	—	—	—	Sep 18, 2013	9.73K	—	—	—

Showing 2 results

Achaogen Inc

Investor

Updated Mar 11, 2014


Form 3	—	—	—	—	Mar 11, 2014	—	—	—	—

Showing 1 results